NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹11 Cr | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATH BIOGENES (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹11 Cr |
Mar2024 | ₹39 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹-25 Cr |
Mar2013 | ₹-0.81 Cr |
How is Net Cash Inflow / Outflow of NATH BIOGENES (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹11 Cr | -70.85 | |
Mar2024 | ₹39 Cr | 16.56 | |
Mar2023 | ₹34 Cr | Positive | |
Mar2022 | ₹-25 Cr | Negative | |
Mar2013 | ₹-0.81 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹315.5 Cr | -2.8% | -4.8% | -22.9% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,198.4 Cr | 0.3% | 2.4% | -29.1% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,007.6 Cr | -1.6% | 9.1% | 3.1% | Stock Analytics | |
VENKYS (INDIA) | ₹2,135.2 Cr | 1.7% | 0.5% | -39.4% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,436.3 Cr | -4.9% | 2% | -29.3% | Stock Analytics | |
INDO US BIOTECH | ₹295.9 Cr | 1.7% | -12.6% | -50.5% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -2.8% |
-4.8% |
-22.9% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses